The first major randomized clinical trial on the effect of disclosing genetic information found that people who decided to learn about their genetic risk of developing Alzheimer’s disease did not experience large, negative psychological impacts.
Bioethicists worried patients couldn’t handle their own genetic testing results. They were (mostly) wrong
STAT |
July 2019
Press